Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 7c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.65 million versus the consensus estimate of $9.39 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• KBAT Group files for 6.25M share IPO at $4-$5/sh